A detailed history of Bank Of Montreal transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 176,840 shares of SRPT stock, worth $26.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
176,840
Previous 152,550 15.92%
Holding current value
$26.8 Million
Previous $14.7 Million 55.63%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$93.7 - $141.53 $2.28 Million - $3.44 Million
24,290 Added 15.92%
176,840 $22.9 Million
Q4 2023

Feb 08, 2024

SELL
$67.31 - $124.76 $8.05 Million - $14.9 Million
-119,663 Reduced 43.96%
152,550 $14.7 Million
Q3 2023

Nov 01, 2023

BUY
$102.5 - $123.59 $17.9 Million - $21.5 Million
174,299 Added 178.01%
272,213 $33 Million
Q2 2023

Aug 02, 2023

BUY
$106.4 - $157.19 $4.53 Million - $6.69 Million
42,565 Added 76.9%
97,914 $11.2 Million
Q1 2023

Jun 13, 2024

SELL
$117.53 - $155.99 $16.7 Million - $22.1 Million
-141,847 Reduced 80.21%
34,993 $4.82 Million
Q4 2022

Feb 01, 2023

SELL
$100.86 - $132.13 $479,589 - $628,278
-4,755 Reduced 7.91%
55,349 $7.17 Million
Q3 2022

Nov 10, 2022

SELL
$75.71 - $119.24 $3.6 Million - $5.66 Million
-47,492 Reduced 44.14%
60,104 $6.76 Million
Q2 2022

Aug 11, 2022

SELL
$62.69 - $88.44 $23.4 Million - $33.1 Million
-373,770 Reduced 77.65%
107,596 $8.15 Million
Q1 2022

May 12, 2022

BUY
$63.15 - $90.42 $29.1 Million - $41.7 Million
460,768 Added 2236.96%
481,366 $37.8 Million
Q4 2021

Feb 11, 2022

SELL
$77.28 - $99.42 $20.2 Million - $26 Million
-261,711 Reduced 92.7%
20,598 $1.87 Million
Q3 2021

Nov 12, 2021

BUY
$65.97 - $92.48 $18.3 Million - $25.7 Million
277,393 Added 5642.66%
282,309 $25.6 Million
Q2 2021

Aug 12, 2021

BUY
$69.38 - $86.75 $341,072 - $426,463
4,916 New
4,916 $395,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.3B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.